S. Bodendiek

Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion

H. Wulff, B. Zhorov, P. Zimin, 2010, Molecular Pharmacology.

Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs

H. Wulff, R. Köhler, P. Bie, 2012, British journal of pharmacology.

The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke

G. Raman, H. Wulff, M. O’Donnell, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

The KCa3.1 blocker TRAM‐34 reduces infarction and neurological deficit in a rat model of reperfusion stroke

G. Raman, H. Wulff, M. O’Donnell, 2011 .

4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3.

H. Wulff, S. Bodendiek, Cédrick Mahieux, 2009, European journal of medicinal chemistry.

Connexin modulators and their potential targets under the magnifying glass.

S. Bodendiek, G. Raman, Bodendiek Sb, 2010, Current medicinal chemistry.

Triarylmethanes, a New Class of Cx50 Inhibitors

D. P. Jenkins, H. Wulff, M. P. Trelles, 2012, Front. Pharmacol..

Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion

H. Wulff, B. Zhorov, Bojan Garic, 2010, Molecular Pharmacology.